Stéphanie McArdle

1.8k total citations
64 papers, 1.3k citations indexed

About

Stéphanie McArdle is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Stéphanie McArdle has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 24 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Stéphanie McArdle's work include Immunotherapy and Immune Responses (33 papers), Cancer Immunotherapy and Biomarkers (12 papers) and T-cell and B-cell Immunology (12 papers). Stéphanie McArdle is often cited by papers focused on Immunotherapy and Immune Responses (33 papers), Cancer Immunotherapy and Biomarkers (12 papers) and T-cell and B-cell Immunology (12 papers). Stéphanie McArdle collaborates with scholars based in United Kingdom, France and Denmark. Stéphanie McArdle's co-authors include Robert C. Rees, Divya Nagarajan, A. Graham Pockley, Stefania Cuzzubbo, Sara M. Mangsbo, Shahzad I. Mian, Selman Ali, M. C. Bishop, Stephen Reeder and Geng Li and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Stéphanie McArdle

62 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stéphanie McArdle United Kingdom 22 547 523 399 163 116 64 1.3k
Christopher J. Bagley Australia 24 673 1.2× 637 1.2× 294 0.7× 89 0.5× 94 0.8× 37 1.8k
Rachel A. Gottschalk United States 17 494 0.9× 1.2k 2.2× 440 1.1× 167 1.0× 155 1.3× 36 1.9k
Christina Hesse Germany 17 455 0.8× 819 1.6× 235 0.6× 107 0.7× 148 1.3× 36 1.6k
Katherine Oravecz-Wilson United States 23 696 1.3× 418 0.8× 273 0.7× 86 0.5× 167 1.4× 50 1.3k
Hanna Rokita Poland 24 738 1.3× 437 0.8× 316 0.8× 83 0.5× 190 1.6× 68 1.4k
Yuekang Xu China 25 629 1.1× 1.4k 2.8× 383 1.0× 67 0.4× 150 1.3× 53 2.3k
Douglas A. Weidner United States 22 965 1.8× 226 0.4× 374 0.9× 76 0.5× 156 1.3× 46 1.7k
Georg Greiner Austria 20 560 1.0× 500 1.0× 273 0.7× 56 0.3× 119 1.0× 61 1.2k
Jiandong Zhang China 14 356 0.7× 295 0.6× 283 0.7× 88 0.5× 108 0.9× 36 988
Yuh‐Pyng Sher Taiwan 24 778 1.4× 382 0.7× 453 1.1× 299 1.8× 373 3.2× 52 1.7k

Countries citing papers authored by Stéphanie McArdle

Since Specialization
Citations

This map shows the geographic impact of Stéphanie McArdle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie McArdle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie McArdle more than expected).

Fields of papers citing papers by Stéphanie McArdle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphanie McArdle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie McArdle. The network helps show where Stéphanie McArdle may publish in the future.

Co-authorship network of co-authors of Stéphanie McArdle

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphanie McArdle. A scholar is included among the top collaborators of Stéphanie McArdle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphanie McArdle. Stéphanie McArdle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pearson, Joshua R. D., Murrium Ahmad, Victoria A. Brentville, et al.. (2024). TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors. Cancer Immunology Immunotherapy. 73(9). 178–178. 4 indexed citations
2.
Pearson, Joshua R. D., Phuong Vu, Md. Asaduzzaman Khan, et al.. (2023). Anticancer actions of carnosine in cellular models of prostate cancer. Journal of Cellular and Molecular Medicine. 28(2). e18061–e18061. 4 indexed citations
3.
Cuzzubbo, Stefania, et al.. (2021). Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments. Frontiers in Immunology. 11. 615240–615240. 89 indexed citations
4.
Nasi, Aikaterini, Stéphanie McArdle, Gustav Gaudernack, et al.. (2020). Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention. Toxicology Reports. 7. 768–771. 82 indexed citations
5.
6.
McArdle, Stéphanie, et al.. (2019). SP1 and RARα regulate AGAP2 expression in cancer. Scientific Reports. 9(1). 390–390. 12 indexed citations
7.
Hood, Simon, Gemma A. Foulds, Heather Imrie, et al.. (2019). Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation. Frontiers in Immunology. 9. 3169–3169. 21 indexed citations
8.
9.
Abdel-Fatah, Tarek M.A., Stéphanie McArdle, Devika Agarwal, et al.. (2015). HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis. Clinical Cancer Research. 22(4). 905–914. 18 indexed citations
10.
Abdel-Fatah, Tarek M.A., Stéphanie McArdle, Catherine Johnson, et al.. (2014). HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer. British Journal of Cancer. 110(10). 2450–2461. 24 indexed citations
11.
Setty, Srinath, Alessandra Scarpellini, David C. Hughes, et al.. (2011). Expression of transglutaminase-2 isoforms in normal human tissues and cancer cell lines: dysregulation of alternative splicing in cancer. Amino Acids. 44(1). 33–44. 35 indexed citations
12.
Rezvan, Hossein, et al.. (2009). CTL responses to Leishmania mexicana gp63‐cDNA vaccine in a murine model. Parasite Immunology. 31(7). 373–383. 11 indexed citations
13.
Li, Geng, Deepak Assudani, Aija Linē, et al.. (2008). Identification of Metastasis Associated Antigen 1 (MTA1) by Serological Screening of Prostate Cancer cDNA Libraries. PubMed. 2(1). 100–107. 11 indexed citations
14.
15.
Knights, Ashley, Graham Pawelec, Catherine Riley, et al.. (2007). HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides. Cancer Immunology Immunotherapy. 56(12). 1885–1895. 23 indexed citations
16.
Ahmad, Murrium, Robert C. Rees, Stéphanie McArdle, et al.. (2005). Regulation of CTL responses to MHC‐restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4+ T cells in mice failing immunotherapy with DISC–mGM‐CSF. International Journal of Cancer. 115(6). 951–959. 7 indexed citations
17.
Ali, Selman, Murrium Ahmad, C. S. McLean, et al.. (2004). Anti-tumour therapeutic efficacy of OX40L in murine tumour model. Vaccine. 22(27-28). 3585–3594. 43 indexed citations
18.
19.
Parkinson, Richard, Shahzad I. Mian, M.C. Bishop, et al.. (2003). Disabled infectious single cycle herpes simplex virus (DISC‐HSV) is a candidate vector system for gene delivery/expression of GM‐CSF in human prostate cancer therapy. The Prostate. 56(1). 65–73. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher J. Bagley Breakdown of academic impact, for papers by Rachel A. Gottschalk Breakdown of academic impact, for papers by Christina Hesse Breakdown of academic impact, for papers by Katherine Oravecz-Wilson Breakdown of academic impact, for papers by Hanna Rokita Breakdown of academic impact, for papers by Yuekang Xu Breakdown of academic impact, for papers by Douglas A. Weidner Breakdown of academic impact, for papers by Georg Greiner Breakdown of academic impact, for papers by Jiandong Zhang Breakdown of academic impact, for papers by Yuh‐Pyng Sher
Rankless by CCL
2026